Related references
Note: Only part of the references are listed.Ocular Surface Disease and Quality of Life in Patients With Glaucoma
Simon E. Skalicky et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Tafluprost: The First Preservative-Free Prostaglandin to Treat Open-Angle Glaucoma and Ocular Hypertension
Cory Swymer et al.
ANNALS OF PHARMACOTHERAPY (2012)
Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma
William C. Stewart et al.
CURRENT EYE RESEARCH (2011)
Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue
J. Javier Servat et al.
DRUGS & AGING (2011)
Role of fixed combinations in the management of open-angle glaucoma
Anton Hommer
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
Naim Terai et al.
CLINICAL OPHTHALMOLOGY (2011)
Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells
David A. Ammar et al.
ADVANCES IN THERAPY (2010)
Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Robert D. Fechtner et al.
CORNEA (2010)
Impact of dry eye disease and treatment on quality of life
Neil J. Friedman
CURRENT OPINION IN OPHTHALMOLOGY (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
Gregory Katz et al.
CLINICAL OPHTHALMOLOGY (2010)
An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology
Gianluca Martone et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Ocular preservatives: associated risks and newer options
Indu Pal Kaur et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2009)
Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma
Christophe Baudouin
ACTA OPHTHALMOLOGICA (2008)
Dry eyes: etiology and management
Robert Latkany
CURRENT OPINION IN OPHTHALMOLOGY (2008)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
Doctor-patient communication, health-related beliefs, and adherence in glaucoma
David S. Friedman et al.
OPHTHALMOLOGY (2008)
Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%
Robert M. Feldman et al.
OPHTHALMOLOGY (2007)
Impact of dry eye syndrome on vision-related quality of life
Biljana Miljanovic et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Persistence and adherence with topical glaucoma therapy
BL Nordstrom et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Management of glaucoma: Focus on pharmacological therapy
RE Marquis et al.
DRUGS & AGING (2005)
Compliance barriers in glaucoma: A systematic classification
JC Tsai et al.
JOURNAL OF GLAUCOMA (2003)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Share Paper
